At this time, MYGN has an average Growth Score of C. However, its Momentum is doing a lot better with an A. Charting a somewhat similar path, the stock was allocated a grade of B on the value side, putting it in the second quintile for this …
SmarTrend identified a Downtrend for Myriad Genetics (NASDAQ:MYGN) on February 5th, 2018 at $35.24. In approximately 1 month, Myriad Genetics has returned 12.85% as of today's recent price of $30.71. In the past 52 …
For a hedged play on Myriad Genetics (MYGN), MarketIntelligenceCenter.com’s option-trade picking algorithms recommend the May 18, 2018 $30 covered call for a net debit in the $28.30 area. That is also the break-even stock
BENSALEM, Pa.--(BUSINESS WIRE)-- Law Offices of Howard G. Smith announces an investigation on behalf of Myriad …
Myriad's stock just completed a long-term bottom in May 2017 ... One of those companies with potential is Myriad Genetics (MYGN). Myriad creates genetic tests to screen for genetic cancer risk and other diseases. It’s currently …
Myriad Genetics Inc. (MYGN) reported fourth quarter EPS of $0.30 after the bell ... Shares finished up by 2.43 at $27.98 on above average volume. The stock broke out of a month and a half long trading range and set nearly a 52-week high.
For a hedged play on Myriad Genetics (MYGN), MarketIntelligenceCenter.com’s option-trade picking algorithms recommend the Apr 20, 2018 $32 covered call for a net debit in the $30.78 area. That is also the break-even stock price …
Myriad Genetics, Inc. MYGN was a big mover last session, as its shares rose over 5% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for …